Kevin Herwig discussed alternative funding programs at the National Intellectual Property Rights Coordination’s Pharmaceutical Symposium, highlighting the harms of these schemes which delay or block access to life-saving drugs, and often try to force patients to obtain life-saving medications through illegal importation. He urged government regulators to take action to enforce the law, investigate AFP business practices, and close the loopholes that enable them to operate.

read more